Share
“Civilization begins with distillation,” said William Faulkner, a writer and drinker. Although our thirst for alcohol dates back to the Stone Age, nobody has figured out a good way to deal with the ensuing hangover after getting drunk.
As a chemical engineering professor and wine enthusiast, I felt I needed to find a solution. As frivolous as this project may sound, it has serious implications. Between 8 and 10 percent of emergency room visits in America are due to acute alcohol poisoning. Alcohol is the leading risk factor for premature deaths and disability among people aged 15-49 and its abuse leads to serious health problems, including cardiovascular and liver cancer. Despite these sobering facts, current treatments for alcohol overdose largely rely on the body’s own enzymes to break down this drug.

Yunfeng Lu
Together with professor Cheng Ji, an expert in liver diseases from Keck School of Medicine at the University of Southern California, and my graduate student Duo Xu, we developed an antidote and tested it in mice.
To protect the enzymes, we wrapped each of them in a shell, using a material the U.S. Food and Drug Administration had already approved for pills. We then injected these nanocapsules into the veins of drunk mice where they hurtled through the circulatory system, eventually arriving in the liver where they entered the cells and served as mini–reactors to digest alcohol.
We showed that in inebriated mice (which fall asleep much faster than drunk humans), the treatment decreased the blood alcohol level by 45 percent in just four hours compared to mice that didn’t receive any. Meanwhile, the blood concentration of acetaldehyde – a highly toxic compound that is carcinogenic, causes headaches and vomiting, makes people blush after drinking, and is produced during the normal alcohol metabolism – remained extremely low. The animals given the drug woke from their alcohol-induced slumber faster than their untreated counterparts – something all college students would appreciate.
We are currently completing tests to ensure that our nanocapsules are safe and don’t trigger unexpected or dangerous side effects. If our treatments prove effective in animals, we could begin human clinical trials in as early as one year.

Yunfeng Lu, Professor Chemical and Biomolecular Engineering, University of California, Los Angeles
This article was originally published on The Conversation. Read the original article.
Trump Says Xi Told Him China Will Not Invade Taiwan While He Is US President
1 day ago
Melania Trump Sends Letter to Putin About Abducted Children
1 day ago
Category 4 Hurricane Erin Continues to Intensify, NHC Says
1 day ago
US Stops Visitor Visas for People From Gaza
1 day ago
Trump Says No Summit Deal With Putin Over Ukraine War, Talks Were ‘Very Productive’
2 days ago
Tulare County Man Guilty of Multiple Lewd Acts on Child
2 days ago
Sanger Police Arrest Second Suspect Charged in Juvenile Shooting
2 days ago
Complaint Filed Against Judge in NW Fresno Luxury Apartment Case
2 days ago
Madera County Man Arrested in Fatal Crash Case
2 days ago
What Can MLB Learn From the Savannah Bananas? A Lot, It Turns Out.
5 hours ago
Categories

What Can MLB Learn From the Savannah Bananas? A Lot, It Turns Out.

How Do We Bridge America’s New Segregation?

Micky MaKenzie, Bold Pup With a Big Heart, Ready for a New Home

Trump Says Xi Told Him China Will Not Invade Taiwan While He Is US President

Melania Trump Sends Letter to Putin About Abducted Children

Category 4 Hurricane Erin Continues to Intensify, NHC Says

US Stops Visitor Visas for People From Gaza
